Volume 6, Issue 2 (6-2024)
alkhass 2024, 6(2): 1-9 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sedaghat H, Chaboki M, Esmaeilzadeh M. Berberine: Structure, Applications, Efficacy, and Recent Achievements. alkhass 2024; 6 (2) :1-9
URL: http://alkhass.srpub.org/article-4-215-en.html
URL: http://alkhass.srpub.org/article-4-215-en.html
IR_TAK_41/796234, Development, Economy and Entrepreneurship Holding (TAK) Tehran, Iran
Abstract: (147 Views)
Berberine, a natural isoquinoline alkaloid, has attracted considerable attention for its diverse pharmacological properties. Extracted from plants like “Berberis” species and “Coptis chinensis”, berberine has been used in traditional medicine systems for centuries. Modern research has unveiled its significant potential in managing metabolic syndromes, cardiovascular disorders, microbial infections, and cancer. This review provides an in-depth analysis of berberine’s mechanisms of action, therapeutic applications, clinical efficacy, and safety profile. Although promising, challenges such as low bioavailability and limited high-quality clinical trials need to be addressed to realize its full potential.
Keywords: Berberine, Metabolic syndromes, Cardiovascular disorders, Microbial infections, Cancer, Therapeutic applications, Clinical efficacy
Type of Study: Applicable |
Subject:
Nutraceuticals and functional foods
Received: 2024/03/10 | Revised: 2024/04/15 | Accepted: 2024/05/23 | Published: 2024/06/25
Received: 2024/03/10 | Revised: 2024/04/15 | Accepted: 2024/05/23 | Published: 2024/06/25
References
1. Ye Y, Liu X, Wu N, Han Y, Wang J, Yu Y, Chen Q. Efficacy and safety of berberine alone for several metabolic disorders: a systematic review and meta-analysis of randomized clinical trials. Frontiers in pharmacology. 2021;26(12):653887. [DOI:10.3389/fphar.2021.653887] [PMID] [PMCID]
2. Wang H, Zhang H, Gao Z, Zhang Q, Gu C. The mechanism of berberine alleviating metabolic disorder based on gut microbiome. Frontiers in cellular and infection microbiology. 2022; 25(12):854885. [DOI:10.3389/fcimb.2022.854885] [PMID] [PMCID]
3. Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, Barrea L, Hassan ST, Šmejkal K, Malaník M, Sychrová A. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics. 2019;9(7):1923. [DOI:10.7150/thno.30787] [PMID] [PMCID]
4. Chang W, Chen L, Hatch GM. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. Biochemistry and cell biology. 2015;93(5):479-86. [DOI:10.1139/bcb-2014-0107] [PMID]
5. Gasmi A, Asghar F, Zafar S, Oliinyk P, Khavrona O, Lysiuk R, Peana M, Piscopo S, Antonyak H, Pen JJ, Lozynska I. Berberine: Pharmacological features in health, disease and aging. Current Medicinal Chemistry. 2024;31(10):1214-34. [DOI:10.2174/0929867330666230207112539] [PMID]
6. Rauf A, Abu-Izneid T, Khalil AA, Imran M, Shah ZA, Emran TB, Mitra S, Khan Z, Alhumaydhi FA, Aljohani AS, Khan I. Berberine as a potential anticancer agent: A comprehensive review. Molecules. 2021;26(23):7368. [DOI:10.3390/molecules26237368] [PMID] [PMCID]
7. Caliceti C, Franco P, Spinozzi S, Roda A, FG Cicero A. Berberine: new insights from pharmacological aspects to clinical evidences in the management of metabolic disorders. Current Medicinal Chemistry. 2016 ;23(14):1460-76.. [DOI:10.2174/0929867323666160411143314] [PMID]
8. Dan L, Hao Y, Li J, Wang T, Zhao W, Wang H, Qiao L, Xie P. Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer's disease: a systematic review and meta-analysis. Frontiers in Pharmacology. 2024;14:1287750. [DOI:10.3389/fphar.2023.1287750] [PMID] [PMCID]
9. García-Muñoz AM, Victoria-Montesinos D, Ballester P, Cerdá B, Zafrilla P. A Descriptive Review of the Antioxidant Effects and Mechanisms of Action of Berberine and Silymarin. Molecules. 2024;29(19):4576. [DOI:10.3390/molecules29194576] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |